Efficacy and safety of dietary supplements containing CLA for the treatment of obesity

This publication has 70 references indexed in Scilit:

• trans-10,cis-12 CLA inhibits differentiation of 3T3-L1 adipocytes and decreases PPARγ expression
  Biochemical and Biophysical Research Communications, 2003
• PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
  International Journal of Obesity, 2003
• Conjugated linoleic acid decreases fat accretion in pigs: evaluation by dual-energy X-ray absorptiometry
  British Journal of Nutrition, 2003
• Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse
  Journal of Lipid Research, 2002
• Dietary supplementation with conjugated linoleic acid does not improve nutritional status of tumor‐bearing rats*
  Research in Nursing & Health, 2002
• Conjugated Linoleic Acid Reduces Body Fat in Healthy Exercising Humans
  Journal of International Medical Research, 2001
• Conjugated linoleic acid: a novel therapeutic nutrient?
  Nutrition Research Reviews, 2001
• The role of dairy products in supplying conjugated linoleic acid to man’s diet: a review
  Nutrition Research Reviews, 2001
• Conjugated linoleic acid activates peroxisome proliferator-activated receptor α and β subtypes but does not induce hepatic peroxisome proliferation in Sprague–Dawley rats
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
• Conjugated Linoleic Acid Decreases Hepatic Stearoyl-CoA Desaturase mRNA Expression
  Biochemical and Biophysical Research Communications, 1998